<DOC>
	<DOCNO>NCT01144624</DOCNO>
	<brief_summary>The two co-primary objective study assess Japanese patient severe sepsis and/or septic shock : 1 ) safety tolerability two different dos intravenous AZD9773 2 ) PK AZD9773 . The secondary objective make preliminary assessment pharmacodynamics two different dos intravenous AZD9773 Japanese patient severe sepsis and/or septic shock .</brief_summary>
	<brief_title>A Study Assess Safety , Tolerability 2 Doses AZD9773 ( CytoFab™ ) Japanese With Severe Sepsis/Septic Shock</brief_title>
	<detailed_description />
	<mesh_term>Shock</mesh_term>
	<mesh_term>Sepsis</mesh_term>
	<mesh_term>Toxemia</mesh_term>
	<mesh_term>Shock , Septic</mesh_term>
	<criteria>Japanese adult first episode sepsis hospitalisation objective evidence infection require parenteral antibiotic . At least 2 4 SIRS criterion 24 hour organ dysfunction ( must include either fever OR elevate white blood cell [ WBC ] ) Cardiovascular respiratory dysfunction . Immunocompromising comorbidities concomitant medication : 1 . Advanced human immunodeficiency virus ( HIV ) infection ( CD4 ≤50/mm3 ) . 2 . Haemopoietic lymphoreticular malignancy remission . 3 . Receiving radiation therapy chemotherapy . 4 . Any organ bone marrow transplant within past 24 week . 5 . Absolute neutrophil count &lt; 500 per μL . 6 . High dose steroid immunocompromising drug . Concomitant disease : 1 . Deepseated fungal infection active tuberculosis . 2 . Severe chronic liver disease associate portal hypertension , cirrhosis , chronic ascites ChildPugh class C. 3 . History chronic hypercarbia , respiratory failure past 6 month use home oxygen set severe chronic respiratory disease . 4 . Neuromuscular disorder impact breathing/spontaneous ventilation . 5 . Quadriplegia . 6 . Cardiac arrest past 30 day . 7 . New York Heart Association functional Class III IV due heart failure disorder . 8 . Burns &gt; 30 % body surface area past 5 day . Medication allergy disqualification . 1 . Treatment antiTNF agent within last 8 week . 2 . Previously receive ovine derive product ( CroFab™ , DigiFab™ ) . 3 . Sheep product allergy allergy papain , chymopapain .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2014</verification_date>
	<keyword>TNF neutralisation</keyword>
</DOC>